LOGICBIO THERAPEUTICS
LogicBio develops gene therapy vectors for previously incurable genetic and infectious diseases. It is committed to delivering genetic medicine to pediatric patients with rare diseases. Their proprietary technology based on the non-pathogenic adeno-associated viral vector offers superior efficiency and safety compared to all competitors on the market and is uniquely suited for the treatment of children as well as adults.
LOGICBIO THERAPEUTICS
Industry:
Biotechnology Genetics
Founded:
2014-01-01
Address:
Foster City, California, United States
Country:
United States
Website Url:
http://www.logicbio.com
Total Employee:
11+
Status:
Active
Contact:
+1 1042 833 8594
Total Funding:
69 M USD
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible Apple Mobile Web Clips Icon Content Delivery Network Mobile Non Scaleable Content IPv6 YouTube COVID-19 Apple Mobile Web App Capable Google Analytics 4
Similar Organizations
Calimmune
Calimmune is a clinical-stage gene therapy company.
Celsius Therapeutics
Celsius Therapeutics is a biotechnology company that develops precision medicines for cancer and autoimmune disease patients.
CytoMed Therapeutics
CytoMed Therapeutics is a cancer immunotherapy startup.
Leap Therapeutics
Leap Therapeutics is a clinical-stage biopharmaceutical company.
PetMedix
PetMedix is a pet therapeutics startup.
Quell Therapeutics
Quell Therapeutics is a cell therapy company
Voyager Therapeutics
Voyager Therapeutics is a biotechnology company specializing in gene therapy and neurology.
Current Advisors List
Board_member
2018-09-01
Board_member
Board_member
2016-01-01
Board_member
Board_member
2017-06-01
Board_member
Board_member
Board_member
2017-06-01
Current Employees Featured
Leszek Lisowski co-founder @ LogicBio Therapeutics
co-founder
2016-01-01
Adi Barzel Founder @ LogicBio Therapeutics
Founder
2015-08-01
Mark Kay Founder @ LogicBio Therapeutics
Founder
2015-11-01
Matthias Jaffé CFO @ LogicBio Therapeutics
CFO
2017-09-01
Frederic Chereau President & CEO @ LogicBio Therapeutics
President & CEO
2016-04-01
Founder
Stock Details
Investors List
Poalim Equity
Poalim Equity investment in Post-IPO Equity - LogicBio Therapeutics
Oxford Finance LLC
Oxford Finance LLC investment in Post-IPO Debt - LogicBio Therapeutics
Poalim Equity
Poalim Equity investment in Post-IPO Equity - LogicBio Therapeutics
OrbiMed
OrbiMed investment in Series B - LogicBio Therapeutics
Andera Partners
Andera Partners investment in Series B - LogicBio Therapeutics
Biodiscovery V
Biodiscovery V investment in Series B - LogicBio Therapeutics
Arix Bioscience
Arix Bioscience investment in Series B - LogicBio Therapeutics
Pontifax
Pontifax investment in Series B - LogicBio Therapeutics
SBI Japan-Israel Innovation Fund
SBI Japan-Israel Innovation Fund investment in Series B - LogicBio Therapeutics
OrbiMed
OrbiMed investment in Series A - LogicBio Therapeutics
Official Site Inspections
http://www.logicbio.com Semrush global rank: 4.49 M Semrush visits lastest month: 2.4 K
- Host name: server-3-171-38-33.iad61.r.cloudfront.net
- IP address: 3.171.38.33
- Location: Seattle United States
- Latitude: 47.6348
- Longitude: -122.3451
- Metro Code: 819
- Timezone: America/Los_Angeles
- Postal: 98109
More informations about "LogicBio Therapeutics"
LogicBio Therapeutics - Crunchbase Company Profile …
LogicBio develops gene therapy vectors for previously incurable genetic and infectious diseases. It is committed to delivering genetic medicine to pediatric patients with rare diseases. Their proprietary technology based on the non …See details»
LogicBio Therapeutics, Inc. - Drug pipelines, Patents, Clinical trials ...
Explore LogicBio Therapeutics, Inc. with its drug pipeline, therapeutic area, technology platform, 2 clinical trials, 56 news, and 1 literature, Disease Domain:Endocrinology and Metabolic …See details»
Logicbio Therapeutics - Overview, News & Similar companies
Who is Logicbio Therapeutics. LogicBio Therapeutics is a clinical-stage genetic medicine company pioneering genome editing and gene delivery platforms to address rare and seriou s …See details»
LogicBio Therapeutics - Craft
Oct 29, 2024 LogicBio Therapeutics, a genome editing company, focuses on developing medicines to treat rare diseases in patients with unmet medical need using GeneRide …See details»
LogicBio Therapeutics, Inc. - AnnualReports.com
LogicBio Therapeutics is dedicated to extending the reach of genetic medicine with pioneering targeted delivery platforms. LogicBio’s proprietary genome editing technology platform, …See details»
LogicBio Therapeutics Company Profile 2024: …
LogicBio Therapeutics General Information Description. LogicBio Therapeutics Inc is a genome editing company focused on developing medicines to durably treat rare diseases in patients with significant unmet medical need using …See details»
LogicBio Therapeutics, Inc. Company Profile | Lexington, MA ...
Find company research, competitor information, contact details & financial data for LogicBio Therapeutics, Inc. of Lexington, MA. Get the latest business insights from Dun & Bradstreet.See details»
Company LogicBio Therapeutics, Inc. - MarketScreener.com
Mar 31, 2016 LogicBio Therapeutics, Inc. is a clinical-stage genetic medicine company. It is focused on genome editing and gene delivery platforms to address rare and serious diseases …See details»
LogicBio Therapeutics
Nov 7, 2024 LogicBio was founded in 2014 by Bahija Jallal, John Monahan and Jens-Michael Winter, and has since grown to become a cutting-edge biotechnology company with a focus …See details»
LogicBio Therapeutics - LinkedIn
LogicBio Therapeutics | 5,205 followers on LinkedIn. We are a genome editing company developing genetic medicines for the fight against rare pediatric diseases. GeneRide™ is a …See details»
LogicBio Therapeutics Company Overview, Contact Details
GeneRide™ Technology LogicBio Therapeutics utilizes GeneRide™, a promoterless and nuclease-free gene insertion technology that can potentially enhance the safety and efficacy of …See details»
Alexion, AstraZeneca Rare Disease to Acquire LogicBio® …
Oct 3, 2022 This communication is for informational purposes only and is neither an offer to purchase nor a solicitation of an offer to sell securities of LogicBio Therapeutics, Inc. …See details»
LogicBio Therapeutics - Contacts, Employees, Board Members
Organization. LogicBio Therapeutics . Connect to CRM . Save . Summary. Financials. People. Technology. Signals & News. Similar Companies. Highlights. ... LogicBio Therapeutics has 8 …See details»
Logicbio Therapeutics, Inc. Company Profile | Foster City, CA ...
Find company research, competitor information, contact details & financial data for Logicbio Therapeutics, Inc. of Foster City, CA. Get the latest business insights from Dun & Bradstreet.See details»
Governance LogicBio Therapeutics, Inc. BOERSE MUENCHEN
Nov 30, 2018 LogicBio Therapeutics, Inc. is a clinical-stage genetic medicine company. It is focused on genome editing and gene delivery platforms to address rare and serious diseases …See details»
Alexion, AstraZeneca Rare Disease, Completes Acquisition of …
Nov 16, 2022 Frederic Chereau, CEO of LogicBio, will join Alexion as Senior Vice President, Strategy and Business Development. Additional Transaction Details. The tender offer for all of …See details»
Company: LogicBio Therapeutics - CRISPR Medicine
LogicBio Therapeutics develops its GeneRide™ platform as a novel approch to gene editing. The technology harnesses the cells' natural DNA repair processes and does not require an …See details»
LogicBio Therapeutics CEO and Key Executive Team | Craft.co
LogicBio Therapeutics's Director is Frederic Chereau. Other executives include Fred Chereau, President, Chief Executive Officer; Mariana Nacht, Chief Scientific Officer and 5 others. See …See details»
LogicBio Therapeutics
LogicBio Therapeutics is developing genetic medicines to fight against rare pediatric diseases. LogicBio is pioneering safer, site-specific genome editing technology to provide durable …See details»
Alexion, AstraZeneca Rare Disease to Acquire LogicBio® …
Oct 3, 2022 LogicBio acquisition to build on current collaborations and advancements in genomic medicine. LEXINGTON, Mass., Oct. 3, 2022 /PRNewswire/ -- LogicBio® …See details»